Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

3.

Genetic stasis of dominant West Nile virus genotype, Houston, Texas.

Davis CT, Li L, May FJ, Bueno R Jr, Dennett JA, Bala AA, Guzman H, Quiroga-Elizondo D, Tesh RB, Barrett AD.

Emerg Infect Dis. 2007 Apr;13(4):601-4.

4.
5.

Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons.

Herring BL, Bernardin F, Caglioti S, Stramer S, Tobler L, Andrews W, Cheng L, Rampersad S, Cameron C, Saldanha J, Busch MP, Delwart E.

Virology. 2007 Jun 20;363(1):220-8.

6.

Declining growth rate of West Nile virus in North America.

Snapinn KW, Holmes EC, Young DS, Bernard KA, Kramer LD, Ebel GD.

J Virol. 2007 Mar;81(5):2531-4.

7.

Diversity and evolution of West Nile virus in Illinois and the United States, 2002-2005.

Bertolotti L, Kitron U, Goldberg TL.

Virology. 2007 Mar 30;360(1):143-9.

8.
9.

Recent advances in the molecular biology of west nile virus.

Beasley DW.

Curr Mol Med. 2005 Dec;5(8):835-50. Review.

PMID:
16375717
10.

N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity.

Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, Doms RW.

J Virol. 2005 Nov;79(21):13262-74.

11.

Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype.

Davis CT, Ebel GD, Lanciotti RS, Brault AC, Guzman H, Siirin M, Lambert A, Parsons RE, Beasley DW, Novak RJ, Elizondo-Quiroga D, Green EN, Young DS, Stark LM, Drebot MA, Artsob H, Tesh RB, Kramer LD, Barrett AD.

Virology. 2005 Nov 25;342(2):252-65.

12.
13.

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.

Beasley DW, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett AD.

J Virol. 2005 Jul;79(13):8339-47.

14.

Oral transmission of West Nile virus in a hamster model.

Sbrana E, Tonry JH, Xiao SY, da Rosa AP, Higgs S, Tesh RB.

Am J Trop Med Hyg. 2005 Mar;72(3):325-9.

15.

Alligators as West Nile virus amplifiers.

Klenk K, Snow J, Morgan K, Bowen R, Stephens M, Foster F, Gordy P, Beckett S, Komar N, Gubler D, Bunning M.

Emerg Infect Dis. 2004 Dec;10(12):2150-5.

16.

West Nile virus in the vertebrate world.

van der Meulen KM, Pensaert MB, Nauwynck HJ.

Arch Virol. 2005 Apr;150(4):637-57. Review.

PMID:
15662484
18.

Emergence of attenuated West Nile virus variants in Texas, 2003.

Davis CT, Beasley DW, Guzman H, Siirin M, Parsons RE, Tesh RB, Barrett AD.

Virology. 2004 Dec 5;330(1):342-50.

19.

An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development.

Yamshchikov G, Borisevich V, Seregin A, Chaporgina E, Mishina M, Mishin V, Kwok CW, Yamshchikov V.

Virology. 2004 Dec 5;330(1):304-12.

20.

Genetic and phenotypic variation of West Nile virus in New York, 2000-2003.

Ebel GD, Carricaburu J, Young D, Bernard KA, Kramer LD.

Am J Trop Med Hyg. 2004 Oct;71(4):493-500.

Supplemental Content

Support Center